1.
Oscier D, Wade R, Davis Z, Morilla A, Best G, Richards S, Else M, Matutes E, Catovsky D. Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation. Haematologica [Internet]. 2010Sep.30 [cited 2026Nov.22];95(10):1705-12. Available from: https://haematologica.org/article/view/5755